Please login to the form below

Not currently logged in

Lilly snags first approval for sarcoma drug Lartruvo

Eli Lilly HQGranted accelerated approval by the FDA becoming first front-line STS therapy for 40 years

NICE U-turn on Opdivo for kidney cancer

Bristol-Myers Squibb (BMS) buildingBMS sways the watchdog with new data and a patient access scheme

Roche in "unprecedented" launch period for new medicines

Roche Basel SwitzerlandCotellic, Alecensa, Venclexta and Tecentriq position firm to meet 2016 sales targets

UDG Healthcare acquires STEM Marketing for £84m

UDG HealthcareAims to expand its Ashfield service offering

Time for a new language for asthma?

Many patients lack an understanding of what ‘control’ means

Clinical trials enter the genomic age

Looking at the factors driving this change and assessing the benefits

Pharma ramps up its use of Instagram

GSK became the latest firm to join the social network, signing up last month

GlaxoSmithKline GSK Instagram

Immunocore appoints chief financial officer

Paul Fry brings leadership experience from GlaxoSmithKline


Pricing's dodos

Mylan isn’t alone in its outdated practices

darwins medicine

ICON boosts leadership teams

Dr Andrew Garrett, Dr Paul McCracken and Jim Carroll join

Celgene plans real-world study using Apple's ResearchKit

Will develop an iPhone app to assess burden of chronic anaemia

Celgene building

Mastering the rare disease challenge

Identifying expertise and customising communication in orphan drug marketing

PRIME Time in the EU

New pathway promises expedited approvals for innovative medicines

EU flag

Featured jobs

Subscribe to our email news alerts


Add my company

Our higher purpose is to deliver better communication to increase and speed up the ability of patients to access better...

Latest intelligence

Revisiting Instagram for pharma
In pharma, Instagram usage is increasing because it offers so many benefits to engage with patients and HCPs...
The one multichannel question you must ask
There is a question every marketer should ask when designing a multichannel communications strategy...
Medius Deal Watch
Deal Watch September 2016
Abbott, Allergan, Celgene, Moderna, Pfizer and Takeda feature in this month's pharma deals round-up...